Macy Burkhart|
Amy Davis joined the MJ team in 2015 as a client executive in our Benefits Consulting department. Since joining, Amy has held various seats within the department, such as the director of strategy and operations and the vice president of client experience. She is now serving as the vice president of growth + development for the Indiana employee benefits team.
In her role, Amy is responsible for developing and executing the most cost-effective and strategic benefit options for clients in alignment with their business goals and corporate objectives. Amy also oversees the coordination of carrier activities. She acts as the internal conduit between analytics, wellness, communications, and compliance to ensure that all teams within the Benefits Consulting department work seamlessly to execute personalized client strategies.
Related Blogs
Health Care Industry Trends to Watch in 2026
The MJ CompaniesHealth care organizations enter 2026 facing numerous operational, financial and liability pressures, including labor shortages, inflation, supply chain volatility and the impact of U.S. ...
Read More
2025 Ended with Softest Market Conditions Since 2017 for all Account Sizes & Majority of Lines of Business, The Council’s P/C Market Survey Shows
The MJ CompaniesThe market appeared to move further into the soft part of the insurance market cycle in Q4 2025. Premiums across all account sizes rose ...
Read More
Miles for Miles Helps People With Intellectual and Developmental Disabilities Thrive
Britni ShroutMiles Peck loves school as much for the chance to spend time with his friends as for the classroom experience. He is bracing his ...
Read More
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More